Abstract
Abstract
Introduction
Primary total elbow replacement (TER) services in England are being restructured with the goal of centralising care to specialised centres. It is important to monitor the impact of this service redesign. This protocol outlines an intended analysis to provide detailed descriptions of the patients who are receiving primary TER, where and by whom TER is being performed, and what the current surgical practices for TER are in England before the reconfiguration.
Methods
This analysis will use the National Joint Registry (NJR) elbow dataset and link it with NHS England Hospital Episode Statistics-Admitted Patient Care (HES-APC). It will include eligible patients from the start of the NJR elbow dataset in April 2012 to December 2022. The main objective is to determine the incidence of TER in England. Age-sex standardised rates will be calculated for groups including different ethnicities, and socioeconomic backgrounds, using the mid-year population data provided by the Office for National Statistics. This planned analysis will summarise patient characteristics such as age, sex, body mass index (BMI), hand dominance, American Society of Anaesthesiologists (ASA) grade, indication for TER, socioeconomic status, and patient co-morbidities. It will also examine implant fixation type, classification, brand/type, and changes over time in implant types used in England. Additionally, it will explore the characteristics and volume of the surgeons and hospitals providing primary TER services, including the grade of the primary surgeons, funding source for surgery, and admission type. The analysis will cover the number of procedures performed by surgeons and hospitals annually in England and in each region of England. Finally, the planned analysis will summarise the elective wait time, postoperative length of stay, and any serious adverse events or re-admissions within 30 and 90 days after the TER.
Discussion
This protocol describes the first deep dive analysis into the NJR elbow dataset to describe the incidence of TER surgery in England and the characteristics of patients who are receiving it. This analysis will summarise current primary TER practices in England before service reconfigurations. The impact of reconfiguration can be monitored by comparing future practice to the outcomes from this study.
Trial registration ClinicalTrials.gov, NCT06355011. Registered 02 April 2024, https://clinicaltrials.gov/ct2/show/NCT06355011.
Funder
The Royal College of Surgeons of England
National Joint Registry
John Charnley Trust
Centre for Epidemiology Versus Arthritis, University of Manchester
Versus Arthritis
NIHR Biomedical Research Centre at University Hospitals Bristol
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Samdanis V, Manoharan G, Jordan RW, Watts AC, Jenkins P, Kulkarni R, et al. Indications and outcome in total elbow arthroplasty: a systematic review. Shoulder Elbow. 2020;12(5):353–61.
2. Ben-Shlomo Y, Blom A, Boulton C, Brittain R, Clark E, Dawson-Bowling S, et al. National Joint Registry annual reports. The National Joint Registry 19th annual report 2022. London: National Joint Registry; 2022.
3. Hay S, Kulkarni R, Watts A, Stanley D, Trail I, Van Rensburg L, et al. The provision of primary and revision elbow replacement surgery in the NHS. Shoulder Elbow. 2018;10(2 Suppl):S5–12.
4. Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Jt Surg Am. 2004;86(9):1909–16.
5. Lau RL, Perruccio AV, Gandhi R, Mahomed NN. The role of surgeon volume on patient outcome in total knee arthroplasty: a systematic review of the literature. BMC Musculoskelet Disord. 2012;13:250.